DENTI, VANNA
 Distribuzione geografica
Continente #
NA - Nord America 10.322
AS - Asia 6.419
EU - Europa 5.799
SA - Sud America 756
Continente sconosciuto - Info sul continente non disponibili 547
AF - Africa 138
OC - Oceania 33
Totale 24.014
Nazione #
US - Stati Uniti d'America 9.722
IT - Italia 2.963
SG - Singapore 1.788
VN - Vietnam 1.693
CN - Cina 1.189
HK - Hong Kong 623
BR - Brasile 558
DE - Germania 519
RU - Federazione Russa 475
CA - Canada 402
SE - Svezia 314
GB - Regno Unito 292
IE - Irlanda 281
BD - Bangladesh 255
FR - Francia 204
IN - India 193
AT - Austria 139
NL - Olanda 122
KR - Corea 103
ES - Italia 86
JP - Giappone 82
AR - Argentina 70
FI - Finlandia 68
ID - Indonesia 67
UA - Ucraina 67
IQ - Iraq 63
PL - Polonia 62
TR - Turchia 57
CH - Svizzera 52
ZA - Sudafrica 48
MX - Messico 44
PK - Pakistan 41
TW - Taiwan 34
AU - Australia 33
IR - Iran 33
EC - Ecuador 30
CO - Colombia 29
DK - Danimarca 28
CR - Costa Rica 26
SV - El Salvador 26
BE - Belgio 25
IL - Israele 25
SA - Arabia Saudita 25
PH - Filippine 22
VE - Venezuela 22
MA - Marocco 18
MY - Malesia 17
TT - Trinidad e Tobago 17
LT - Lituania 15
SC - Seychelles 15
CL - Cile 14
JM - Giamaica 14
NI - Nicaragua 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
GT - Guatemala 11
RO - Romania 11
TH - Thailandia 11
TN - Tunisia 11
AZ - Azerbaigian 10
JO - Giordania 10
HN - Honduras 9
KE - Kenya 9
NO - Norvegia 9
PE - Perù 9
PR - Porto Rico 9
PT - Portogallo 9
PY - Paraguay 9
BO - Bolivia 7
ET - Etiopia 7
KZ - Kazakistan 7
LB - Libano 7
OM - Oman 7
UY - Uruguay 7
HU - Ungheria 6
AL - Albania 5
DO - Repubblica Dominicana 5
GP - Guadalupe 5
GR - Grecia 5
LV - Lettonia 5
NP - Nepal 5
PA - Panama 5
PS - Palestinian Territory 5
AM - Armenia 4
DZ - Algeria 4
EG - Egitto 4
LU - Lussemburgo 4
MT - Malta 4
RS - Serbia 4
BG - Bulgaria 3
CW - ???statistics.table.value.countryCode.CW??? 3
HR - Croazia 3
HT - Haiti 3
KG - Kirghizistan 3
MN - Mongolia 3
NG - Nigeria 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
BS - Bahamas 2
Totale 23.425
Città #
Ashburn 1.182
Milan 1.153
San Jose 1.060
Singapore 977
Ann Arbor 789
Hong Kong 593
Ho Chi Minh City 509
Hanoi 442
Council Bluffs 420
Dallas 326
Frankfurt am Main 316
Los Angeles 281
Dublin 270
Chandler 248
New York 214
Santa Clara 207
Toronto 192
Wilmington 185
Beijing 175
Fairfield 163
Rome 155
Hefei 141
Chicago 137
Columbus 136
Dearborn 113
Houston 105
Seoul 94
Seattle 93
The Dalles 93
Vienna 92
Phoenix 85
Shanghai 84
Woodbridge 78
São Paulo 77
Buffalo 72
Princeton 71
Orem 61
Montreal 59
Da Nang 58
Lauterbourg 58
Cambridge 57
Turin 54
Tokyo 53
Haiphong 51
Kent 50
Boardman 48
Brooklyn 48
Moscow 48
London 45
Naples 45
Busto Arsizio 44
Denver 44
Atlanta 43
Helsinki 42
Nanjing 42
Warsaw 42
Sesto San Giovanni 39
Washington 39
North Bergen 38
Nuremberg 38
Bologna 37
Ha Long 37
Bắc Ninh 36
Lissone 36
Manchester 36
Jakarta 35
Chennai 34
Cinisello Balsamo 34
Munich 34
Philadelphia 33
Madison 32
Biên Hòa 30
Boston 30
Dong Ket 30
Vũng Tàu 30
Zurich 30
Cagliari 29
Newark 29
Ninh Bình 28
Poplar 28
Quận Bình Thạnh 28
Stockholm 28
Hải Dương 25
Pune 25
Quận Một 24
Thái Nguyên 24
Amsterdam 23
Guangzhou 23
Jacksonville 23
Baghdad 22
Fremont 22
San Francisco 22
Leiden 21
San José 21
San Salvador 21
Austin 20
Can Tho 20
San Diego 20
Basingstoke 19
Dhaka 18
Totale 13.571
Nome #
Hyperoxic recovery impacts on metabolic adaptations induced by hypoxic exercise: A lipidomics approach 692
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 641
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 599
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 578
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 487
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 465
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 458
Sequential MALDI-HiPLEX-IHC and Untargeted Spatial Proteomics Mass Spectrometry Imaging to Detect Proteomic Alterations Associated with Tumour Infiltrating Lymphocytes 446
MiralysTM Ambergen. Sequential MALDI-HiPLEX-IHC and untargeted protein imaging to map the tumour-immune environment: academic researcher experience 436
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 433
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 420
Development of multi-omic mass spectrometry imaging approaches to assist clinical investigations 418
Hyperoxic recovery interferes with the metabolic imprint of hypoxic exercise 413
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 412
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 402
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 398
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 395
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 390
Blood microsampling for untargeted metabolomics: a preliminary study on patients affected by myocardial infarction 385
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 385
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 341
Exploring 6-aza-2-Thiothymine as a MALDI-MSI Matrix for Spatial Lipidomics of Formalin-Fixed Paraffin-Embedded Clinical Samples 338
A molecular imaging approach to individuate tumour infiltrating lymphocytes 322
Mapping the distribution of bioactive compounds and aroma/flavour precursors in green coffee beans with an integrated mass spectrometry-based approach 319
Enhancing proteomics characterization of thyroid nodules: a pixel-classifier for mass spectrometry imaging analyses 312
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 305
Dual Functionalized Liposomes for Selective Delivery of Poorly Soluble Drugs to Inflamed Brain Regions 302
Lipids, proteins, cells: advanced spatial multiomics to delve deeper into the complex molecular and cellular landscape of the tumour microenvironment 293
6-Aza-2-Thiothymine as an Alternative Matrix for Spatial Proteomics with MALDI-MSI 288
Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions 273
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 271
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 270
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 268
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 261
UHPLC-TIMS-PASEF®-MS for Lipidomics: From Theory to Practice 256
Blood microsampling for untargeted metabolomics: a preliminary study on patients affected by myocardial infarction 256
Biomarker identification through spatial proteomics for the characterization of indeterminate thyroid nodules 256
A Mass Spectrometry Imaging-based multiomics approach to map the tumour-immune landscape of clear cell Renal Cell Carcinoma and gain insights into resistance to immunotherapy 255
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 249
Revolutionizing Blood Collection: Innovations, Applications, and the Potential of Microsampling Technologies for Monitoring Metabolites and Lipids 239
What’s brewing? Mapping the distribution of bioactive compounds in green C. arabica coffee beans through MS-driven spatial metabolomics 237
Image segmentation with Bayesian mixtures models for multiomics MSI analyses 236
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 234
MALDI-MSI analysis of lipid alterations in FFPE patient-derived breast cancer xenograft for pre-clinical and clinical application 229
The impact of hyperoxia and hypoxic interval training on the plasma metabolome in skiing athletes 223
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 223
The management of haemoglobin interference for the MALDI-MSI analysis of in-vivo thyroid biopsies 222
Unraveling autophagic imbalances and therapeutic insights in Mecp2-deficient models 221
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 218
Delving deeper into the Tumour Microenvironment: a MS-driven spatial multiomics approach to provide new molecular insights into immune-tumour cell communication 215
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 213
Co-registration of mass spectrometry and optical whole slide histology images for computational pathology 212
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 210
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 209
Advances in thyroglobulin measurement: exploring dried blood spot sampling and mass spectrometry for enhanced clinical utility 205
The interplay of NAD and hypoxic stress and its relevance for ageing 205
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 205
Multi-omic and multimodal characterization of thyroid nodules: novel interplay between molecular and morphological features 204
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 203
Enhanced Detection of Escherichia coli Lipids and Proteins Using Graphene-Polyglycerol Amine via Mass Spectrometry 203
Towards morpho-molecular learning in computational pathology 201
Therapeutic induction of energy metabolism reduces neural tissue damage and increases microglia activation in severe spinal cord injury 201
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 200
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 193
Tri-modal MALDI-MS imaging of lipids, N-Glycans, and proteins on a single tissue section 181
High Intensity Concentric-Eccentric Exercise Under Hypoxia Changes the Blood Metabolome of Trained Athletes 179
6-Aza-2-Thiothymine as a Novel Matrix for MALDI-MSI-Based Lipid Profiling in FFPE Samples 179
Reproducible lipid alterations in patient-derived breast cancer xenograft ffpe tissue identified with maldi msi for pre-clinical and clinical application 177
MMP2-Responsive Liposomes Targeting LDLR Enhance the Effectiveness of Anti-Cancer Drugs in Treating Melanoma 175
Towards lipid MALDI-MS imaging in FFPE tissue: antigen retrieval and its effect on positive ion species 175
Delving deeper into the tissue proteome: improving cell-specificity with high spatial resolution MALDI-MS Imaging 168
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies 158
Improving the Annotation for Spatial Proteomics: A Computational Approach to Enhance Molecular Characterization of Thyroid Nodules 154
Revisiting Thyroglobulin Measurement: Current Methods and Future Perspectives Using Dried Blood Spot Sampling for Enhanced Clinical Practice 151
Understanding the metabolic role of trehalose in inducing autophagy 126
Visualization of Small Intact Proteins in Breast Cancer FFPE Tissue 125
EXPLORING THE MULTI-OMIC LANDSCAPE OF THYROID NODULES: A RETROSPECTIVE STUDY 121
N-Glycan profiling from DBS using the power of timsTOF fleX 121
Exploring 6-Aza-2-Thiothymine as a MALDI-MSI Matrix for Lipid Mapping in FFPE Samples 117
The metabolic role of trehalose in autophagy induction in central nervous system 115
Elaboration Pipeline for the Management of MALDI-MS Imaging Datasets 107
Advancing Thyroid Nodule Diagnosis: Integrating MALDI-MSI for Detailed Characterization of Indeterminate Lesions 102
SPATIAL MULTI-OMICS MALDI-MSI REVEALS MOLECULAR SIGNATURES ACROSS BREAST CANCER SUBTYPES 99
Deceiving on central nervous system trehalose activity 97
MASS SPECTROMETRY APPLICATIONS FOR THE CHARACTERIZATION OF KRAS MUTATIONS IN LUNG CANCER 83
Development and Validation of a nanoLC-TIMS-MS/MS Method for Structural Characterization of Plasma and DBS N-Glycans 83
Sequential MALDI-MSI-Based Multiomics Reveals Spatial Lipid, Glycan, and Tryptic Peptide Signatures in Breast Tumor Histopathology 82
Advances in thyroglobulin measurement: exploring dried blood spot mass spectrometry for enhanced clinical utility 82
Sequential MALDI-MSI-Based Multiomics Reveals Spatial Lipid, Glycan, and Tryptic Peptide Signatures in Breast Tumor Histopathology 81
A New Dimension of Thyroid Biology: Exploring Tissue Complexity through Spatial Multiomics 77
Advancing Thyroid Nodule Diagnosis: Integrating MALDI-MSI for Detailed Characterization of Indeterminate Lesions 76
LC-MS/MS and SISCAPA Technology: A Novel Approach for Accurate Thyroglobulin Quantification Overcoming Antibody Interference 73
Spatial multi-omics insights into transplanted human thyroid organoid via spatial mass spectrometry imaging 73
MULTI-OMIC AND MULTIMODAL CHARACTERIZATION OF THYROID NODULES: NOVEL INTERPLAY BETWEEN MOLECULAR AND MORPHOLOGICAL FEATURES 73
MULTI-OMIC AND MULTIMODAL CHARACTERIZATION OF THYROID NODULES: NOVEL INTERPLAY BETWEEN MOLECULAR AND MORPHOLOGICAL FEATURES 71
Spatial Proteomic Analysis of KRAS-Mutant Lung Cancer 67
Advances in thyroglobulin measurement: exploring dried blood spot mass spectrometry for enhanced clinical utility 66
A novel application of ATT as a MALDI MS matrix for the imaging of tryptic peptides 57
MASS SPECTROMETRY APPLICATIONS FOR THE CHARACTERIZATION OF KRAS MUTATIONS IN LUNG CANCER 52
Comprehensive Spatial Lipidomics of Formalin-Fixed Paraffin-Embedded Tissue Guided by Mass Spectrometry-Imaging 42
Totale 24.014
Categoria #
all - tutte 67.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.258


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022599 0 0 0 125 52 72 7 42 31 49 98 123
2022/20231.164 146 258 137 106 43 159 15 76 87 17 61 59
2023/20241.085 47 35 45 82 91 284 208 42 58 25 59 109
2024/20253.115 91 182 143 104 340 155 216 124 382 490 374 514
2025/202611.065 1.607 828 835 1.231 922 415 1.390 470 739 1.040 683 905
2026/20274.599 758 617 1.424 1.800 0 0 0 0 0 0 0 0
Totale 24.014